Delivery Order SPE2DR25D1053-SPE2DR26FV095
Award Date 12/30/25
Potential Completion Date 1/22/26
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 25, 2025, by the Defense Logistics Agency (DLA) for the supply of Ibrance 100 mg tablets in quantities of seven units. This firm fixed-price delivery order, valued at $17,119.68 with an ultimate completion date of December 17, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-unit package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ibrance 75 mg tablets (quantity 7) with a ceiling value of $8,123.96 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of October 16, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 75 mg tablets (quantity 7) with a ceiling value of $17,122.82. This is a firm fixed price delivery order with an ultimate completion date of January 21, 2026, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The contract does not utilize a set-aside designation,...
- The Defense Logistics Agency awarded a $8,123.96 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ibrance 75 mg tablets (quantity 7 units). This competitive, non-set-aside contract carries a firm fixed price and is scheduled for completion by September 5, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Ibrance 75 mg tablets (quantity 7) with a ceiling value of $8,561.41. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $16,244.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count packaging) on September 9, 2025, with a completion date of September 30, 2025. This firm fixed-price delivery order represents a non-competitive set-aside arrangement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,561.41 for Ibrance 75 mg tablets (7-count units) on December 11, 2025, with completion scheduled for January 5, 2026. This firm fixed-price delivery order represents a non-compete award to the pharmaceutical distributor for supply to federal medical procurement needs. The place of performance is listed as AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ibrance 75 mg tablets (quantity 7) under a firm fixed-price contract with a ceiling value of $8,123.96. The delivery order is scheduled for completion by August 4, 2025. This award represents a non-set-aside, competitively awarded transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,236.16 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (7-count units) on August 25, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...